Drug attributed alterations in potassium handling in congestive cardiac failure
- 1 January 1982
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 23 (1) , 21-25
- https://doi.org/10.1007/bf01061372
Abstract
Information from a comprehensive drug surveillance programme has been reviewed to give details of the frequency of drug-related hypo- and hyperkalaemia in a group of 3879 patients admitted to hospital with cardiac failure. Hypokalaemia was commoner in females, was unrelated to blood area concentration on admission and was twice as common amongst recipients of potassium-losing diuretics who did not take potassium supplements than amongst those who received potassium retaining diuretics. By contrast hyperkalaemia was strongly related to blood urea concentration on admission. It was also related to in-hospital diuretic therapy; being thrice as frequent amongst recipients of aldosterone antagonists than amongst those receiving potassium-losing diuretics without additional supplements. Life-threatening hypo- and hyper-kalaemia were rare in this group of patients with heart failure, occurring with approximately equal frequencies of about 2 per 1000 patients treated.This publication has 24 references indexed in Scilit:
- Hypokalaemia and diuretics: an analysis of publications.BMJ, 1980
- Adverse reactions to frusemide in hospital inpatients.BMJ, 1979
- Potassium depletion in heart failure and its relation to long-term treatment with diuretics: a review of the literaturePublished by Oxford University Press (OUP) ,1978
- Clinical toxicity of furosemide in hospitalized patientsAmerican Heart Journal, 1977
- Diuretics and potassium metabolism: A reassessment of the need, effectiveness and safety of potassium therapyKidney International, 1977
- Paradoxical potassium excretion in response to aldosterone antagonistsEuropean Journal of Clinical Pharmacology, 1977
- Side Effects of Hypotensive Agents Evaluated by a Self-administered QuestionnaireBMJ, 1973
- Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance ProgramJAMA, 1973
- Adverse Reactions to SpironolactoneJAMA, 1973
- Diagnosis and Treatment of Digitalis ToxicityNew England Journal of Medicine, 1965